Skip to content

The randomized, open and positive control study for imaging surgical planning of the pelvic tumors based on 3D printing technology

The randomized, open and positive control study for imaging surgical planning of the pelvic tumors based on 3D printing technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015820
Enrollment
Unknown
Registered
2018-04-23
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic tumors

Interventions

control group:without 3D printed customized guide to assist pelvic tumor surgery
trial group:with 3D printed customized guide to assist pelvic tumor surgery

Sponsors

Ninth People's Hospital, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged 16 years to 85 years; 2. primary pelvic bone tumors without metastasis, or only single metastases; 3. single pelvic metastasis, and the primary focal disease can be effectively controlled; 4. no implant contraindication; 5. No CT and MRI examination contraindication; 6. do not attend any clinical validation within three months; 7. agreed to participate in the study, understand and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. any active systemic and local infection; 2. poor general condition, severe malnutrition or cachexia, poor blood sugar control; 3. multi-bone metastases, missed surgical indications; 4. medical history of metal implants in the pelvis; 5. allergic to the material; 6. not timely follow-up, or for other reasons can't cooperate with researchers; 7. can not accept the new technology.

Design outcomes

Primary

MeasureTime frame
The osteotomy coincidence rate;MSTS score;surgery time;Intraoperative blood transfusion volume;Intraoperative and postoperative complications;remission of tumor symptoms after surgery;

Countries

China

Contacts

Public ContactAi Songtao

Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

ai.songtao@qq.com+86 18019790801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026